SRF published this paper to document and share the critical progress made in advancing SYNGAP1 therapeutic development and to share our roadmap for other patient advocacy groups (PAGs) focused on ...
According to the IMED report, in FY25, some 1,011 projects have had less than 25% physical progress, which is a disappointing outcome. Similarly, 218 projects show progress between 26% and 50%, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback